AI assistant
Adaptive Biotechnologies Corp — Director's Dealing 2019
Jun 27, 2019
31660_dirs_2019-06-26_1f518abb-a808-437f-9851-66b83b2482f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2019-06-26
Reporting Person: NOLAN SEAN PATRICK (Chief Technology Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.98 | 2024-07-08 | Common Stock (400000) | Direct | |
| Stock Option (Right to Buy) | $6.32 | 2026-04-29 | Common Stock (150000) | Direct | |
| Stock Option (Right to Buy) | $6.55 | 2028-02-07 | Common Stock (100000) | Direct | |
| Stock Option (Right to Buy) | $7.27 | 2029-02-07 | Common Stock (100000) | Direct |
Footnotes
F1: The option is fully vested and exercisable.
F2: The options vested with respect to 1/4 of such shares on April 28, 2017, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3: The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F4: The options vest with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.